Variant report
Variant | nsv1051184 |
---|---|
Chromosome Location | chr13:53928195-53956469 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:59)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr13:53931745-53932054 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr13:53931787-53932029 | GM12878 | blood: | n/a | n/a |
3 | CEBPB | chr13:53930565-53930837 | HepG2 | liver: | n/a | chr13:53930701-53930712 chr13:53930701-53930714 |
4 | CEBPB | chr13:53956163-53956639 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | CTCF | chr13:53956256-53956305 | GM12878 | blood: | n/a | n/a |
6 | CTCF | chr13:53956220-53956370 | SK-N-SH_RA | brain: | n/a | n/a |
7 | CTCF | chr13:53943174-53943418 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | CTCF | chr13:53956270-53956354 | HepG2 | liver: | n/a | n/a |
9 | CTCF | chr13:53943161-53943418 | Medullo | brain: | n/a | n/a |
10 | CTCF | chr13:53956217-53956481 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | CTCF | chr13:53943122-53943379 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | CTCF | chr13:53956307-53956358 | Medullo | brain: | n/a | n/a |
13 | CTCF | chr13:53943222-53943334 | MCF-7 | breast: | n/a | n/a |
14 | CTCF | chr13:53943180-53943330 | WERI-Rb-1 | eye: | n/a | n/a |
15 | CTCF | chr13:53943273-53943331 | GM13977 | blood: | n/a | n/a |
16 | CTCF | chr13:53956240-53956390 | HepG2 | liver: | n/a | n/a |
17 | CTCF | chr13:53943264-53943324 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr13:53956189-53956472 | H1-hESC | embryonic stem cell: | n/a | n/a |
19 | CTCF | chr13:53943226-53943326 | GM12878 | blood: | n/a | n/a |
20 | CTCF | chr13:53931440-53931590 | GM12873 | blood: | n/a | n/a |
21 | CTCF | chr13:53956240-53956390 | HEK293 | kidney: | n/a | n/a |
22 | CTCF | chr13:53943180-53943330 | Caco-2 | colon: | n/a | n/a |
23 | CTCF | chr13:53956240-53956390 | SK-N-SH_RA | brain: | n/a | n/a |
24 | CTCF | chr13:53956240-53956390 | Caco-2 | colon: | n/a | n/a |
25 | EBF1 | chr13:53931755-53932009 | GM12878 | blood: | n/a | n/a |
26 | EGR1 | chr13:53931792-53932002 | GM12878 | blood: | n/a | chr13:53931919-53931933 |
27 | EP300 | chr13:53931843-53932042 | GM12878 | blood: | n/a | n/a |
28 | FAM48A | chr13:53939280-53939471 | GM12878 | blood: | n/a | n/a |
29 | FOS | chr13:53939627-53939660 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | GATA3 | chr13:53940181-53940341 | SH-SY5Y | brain: | n/a | n/a |
31 | JUND | chr13:53936448-53936720 | HepG2 | liver: | n/a | n/a |
32 | JUND | chr13:53930506-53930659 | HepG2 | liver: | n/a | n/a |
33 | MAFK | chr13:53936790-53936913 | HepG2 | liver: | n/a | chr13:53936845-53936865 chr13:53936847-53936863 chr13:53936848-53936862 |
34 | MAFK | chr13:53945123-53945323 | HepG2 | liver: | n/a | chr13:53945175-53945186 |
35 | MAZ | chr13:53937807-53937866 | HepG2 | liver: | n/a | n/a |
36 | MXI1 | chr13:53948622-53948733 | GM12878 | blood: | n/a | n/a |
37 | NFE2 | chr13:53933209-53933213 | GM12878 | blood: | n/a | n/a |
38 | POLR2A | chr13:53953122-53953267 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr13:53940089-53940235 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr13:53937744-53938144 | H1-neurons | neurons: | n/a | n/a |
41 | POU2F2 | chr13:53931717-53932036 | GM12891 | blood: | n/a | chr13:53931847-53931860 |
42 | POU2F2 | chr13:53931703-53932085 | GM12891 | blood: | n/a | chr13:53931847-53931860 |
43 | RAD21 | chr13:53943172-53943357 | GM12878 | blood: | n/a | n/a |
44 | RAD21 | chr13:53956166-53956465 | H1-hESC | embryonic stem cell: | n/a | n/a |
45 | RAD21 | chr13:53943057-53943474 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | RAD21 | chr13:53956129-53956511 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | RAD21 | chr13:53956179-53956525 | H1-hESC | embryonic stem cell: | n/a | n/a |
48 | RAD21 | chr13:53943071-53943509 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | RAD21 | chr13:53943075-53943470 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | RELA | chr13:53931648-53932345 | GM12891 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000220990 | TF binding region |
ENSG00000220990 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535354736 | chr13:53934961-53934962 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs183551013 | chr13:53934984-53934985 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs540350831 | chr13:53935009-53935010 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs570724995 | chr13:53935030-53935031 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs539930186 | chr13:53935076-53935077 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs546728532 | chr13:53935143-53935144 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs188600184 | chr13:53935185-53935186 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs35894645 | chr13:53935296-53935297 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs534799034 | chr13:53935350-53935351 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs200449230 | chr13:53935440-53935441 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs574762073 | chr13:53935442-53935443 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs370412917 | chr13:53935503-53935504 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs536918732 | chr13:53935636-53935637 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs138080639 | chr13:53935643-53935644 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs560255698 | chr13:53935645-53935646 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs8001044 | chr13:53935676-53935677 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs9596792 | chr13:53935689-53935690 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs573135545 | chr13:53935696-53935697 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs2587359 | chr13:53935709-53935710 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs561920301 | chr13:53935752-53935753 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs192740684 | chr13:53935796-53935797 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs544539578 | chr13:53935800-53935801 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs73201848 | chr13:53935813-53935814 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs184172945 | chr13:53935839-53935840 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs533168991 | chr13:53935870-53935871 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs547109366 | chr13:53935876-53935877 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs116334071 | chr13:53935888-53935889 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs528323131 | chr13:53935995-53935996 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs150648972 | chr13:53936001-53936002 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs568225006 | chr13:53936010-53936011 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs576190745 | chr13:53936038-53936039 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs537355529 | chr13:53936063-53936064 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs556973950 | chr13:53936078-53936079 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs7981317 | chr13:53936098-53936099 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs11618497 | chr13:53936109-53936110 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs552681615 | chr13:53936141-53936142 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs572628119 | chr13:53936163-53936164 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs188357912 | chr13:53936226-53936227 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs570855030 | chr13:53936278-53936279 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs1443905 | chr13:53936286-53936287 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs34183575 | chr13:53936307-53936308 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs8002469 | chr13:53936313-53936314 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs544934315 | chr13:53936314-53936315 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs371987564 | chr13:53936329-53936330 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs376639594 | chr13:53936365-53936366 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs1443904 | chr13:53936386-53936387 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs533394959 | chr13:53936387-53936388 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs191803078 | chr13:53936388-53936389 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs560483259 | chr13:53936408-53936409 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs545099878 | chr13:53936499-53936500 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Schizophrenia | 20967226 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:53935400-53935600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr13:53935600-53936200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr13:53935600-53936200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr13:53935600-53937600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr13:53936200-53937400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr13:53936200-53937800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr13:53937400-53939200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr13:53937600-53939200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
9 | chr13:53937600-53939400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr13:53937800-53939400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr13:53937800-53939400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr13:53938000-53939400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr13:53938800-53939200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr13:53947600-53948000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr13:53948000-53949000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr13:53948600-53949400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
17 | chr13:53948600-53949400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
18 | chr13:53949000-53949600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr13:53949200-53949400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr13:53949200-53949600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
21 | chr13:53949400-53949800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
22 | chr13:53953200-53954600 | Enhancers | Liver | Liver |
23 | chr13:53956000-53956600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
24 | chr13:53956000-53956600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
25 | chr13:53956000-53956800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
26 | chr13:53956200-53956600 | Enhancers | H1 Cell Line | embryonic stem cell |
27 | chr13:53956200-53956600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
28 | chr13:53956400-53956800 | Enhancers | H9 Cell Line | embryonic stem cell |